Advances in Omics Technologies in GBM
Glioblastoma multiforme (GBM) is one of the most lethal human cancers and poses a great challenge in the therapeutic interventions of GBM patients worldwide. Despite prominent recent advances in oncology, on an average GBM patients survive 12–15 months with conventional standard of care treatment. T...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wolters Kluwer Medknow Publications
2015-01-01
|
| Saila: | Biomedical Research Journal |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.brjnmims.org/article.asp?issn=2349-3666;year=2015;volume=2;issue=1;spage=6;epage=20;aulast=Maachani;type=0 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|